The Human Low Affinity Fcγ Receptors IIa, IIb, and III Bind IgG with Fast Kinetics and Distinct Thermodynamic Properties*
暂无分享,去创建一个
David I. Stuart | D. Stuart | E. Jones | P. A. van der Merwe | K. Maenaka | E. Yvonne Jones | Katsumi Maenaka | Peter Sondermann | P. Sondermann | P. Anton van der Merwe | David I. Stuart | E. Jones
[1] M. Kasahara. The chromosomal duplication model of the major histocompatibility complex , 1999, Immunological reviews.
[2] M. Cooper,et al. Paired Ig-like receptor homologs in birds and mammals share a common ancestor with mammalian Fc receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[3] P. Selvaraj,et al. The Membrane Anchor Influences Ligand Binding Two-dimensional Kinetic Rates and Three-dimensional Affinity of FcγRIII (CD16)* , 2000, The Journal of Biological Chemistry.
[4] P. Linsley,et al. CD80 (B7-1) Binds Both CD28 and CTLA-4 with a Low Affinity and Very Fast Kinetics , 1997, The Journal of experimental medicine.
[5] F. Ennis,et al. HUMAN IgG FC RECEPTOR I 1 MEDIATES ANTIBODY-DEPENDENT ENHANCEMENT OF DENGUE VIRUS INFECTION ' , 2001 .
[6] U. Jacob,et al. Characterization and crystallization of soluble human Fc gamma receptor II (CD32) isoforms produced in insect cells. , 1999, Biochemistry.
[7] K. Tsumoto,et al. Thermodynamic Consequences of Grafting Enhanced Affinity toward the Mutated Antigen onto an Antibody , 2000, The Journal of Biological Chemistry.
[8] P. Parren,et al. The IgG Fc Contains Distinct Fc Receptor (FcR) Binding Sites: The Leukocyte Receptors FcγRI and FcγRIIa Bind to a Region in the Fc Distinct from That Recognized by Neonatal FcR and Protein A1 , 2000, The Journal of Immunology.
[9] W. Stites,et al. Protein−Protein Interactions: Interface Structure, Binding Thermodynamics, and Mutational Analysis , 1997 .
[10] C. Jacquillat,et al. Changes of soluble CD16 levels in serum of HIV-infected patients: correlation with clinical and biologic prognostic factors. , 1990, The Journal of infectious diseases.
[11] J. Kinet,et al. Crystal Structure of the Human High-Affinity IgE Receptor , 1998, Cell.
[12] A. Barclay,et al. Affinity and Kinetic Analysis of L-selectin (CD62L) Binding to Glycosylation-dependent Cell-adhesion Molecule-1* , 1998, The Journal of Biological Chemistry.
[13] D. Stuart,et al. Crystal structure of the human p58 killer cell inhibitory receptor (KIR2DL3) specific for HLA-Cw3-related MHC class I. , 1999, Structure.
[14] J. Strominger,et al. Molecular analyses of the interactions between human NK receptors and their HLA ligands. , 2000, Human immunology.
[15] P. Barton,et al. Crystal structure of the human leukocyte Fc receptor, FcγRIIa. , 1999, Nature Structural Biology.
[16] R. Kimberly,et al. Cell type-specific glycoforms of Fc gamma RIIIa (CD16): differential ligand binding. , 1997, Journal of immunology.
[17] J. Strominger,et al. Kinetics of interaction of HLA-C ligands with natural killer cell inhibitory receptors. , 1998, Immunity.
[18] Robert Huber,et al. The 3.2-Å crystal structure of the human IgG1 Fc fragment–FcγRIII complex , 2000, Nature.
[19] U. Jacob,et al. Crystal structure of the soluble form of the human Fcγ‐receptor IIb: a new member of the immunoglobulin superfamily at 1.7 Å resolution , 1999, The EMBO journal.
[20] G. Gao,et al. Killer Cell Immunoglobulin Receptors and T Cell Receptors Bind Peptide-Major Histocompatibility Complex Class I with Distinct Thermodynamic and Kinetic Properties* , 1999, The Journal of Biological Chemistry.
[21] D. Mason,et al. Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with a very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59. , 1994, Biochemistry.
[22] W A Hendrickson,et al. Energetics of the HIV gp120-CD4 binding reaction. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[23] R. S. Spolar,et al. Coupling of local folding to site-specific binding of proteins to DNA. , 1994, Science.
[24] S. Yoo,et al. Thermodynamic study of the pH-dependent interaction of chromogranin A with an intraluminal loop peptide of the inositol 1,4,5-trisphosphate receptor. , 1995, Biochemistry.
[25] M. Hulett,et al. Identification of residues in the first domain of human Fc alpha receptor essential for interaction with IgA. , 1999, Journal of immunology.
[26] R. Karlsson,et al. Experimental design for kinetic analysis of protein-protein interactions with surface plasmon resonance biosensors. , 1997, Journal of immunological methods.
[27] D. Khayat,et al. Cell-free Fc-gamma receptor III in sera from patients with systemic lupus erythematosus: correlation with clinical and biological features. , 1994, International archives of allergy and immunology.
[28] C. Daly,et al. A soluble form of Fc gamma RIII is present in human serum and other body fluids and is elevated at sites of inflammation. , 1992, Blood.
[29] U. Jacob,et al. Human Fc gamma Receptor IIb Expressed in Escherichia coli Reveals IgG Binding Capability , 1999, Biological chemistry.
[30] U. Jacob,et al. Molecular basis for immune complex recognition: a comparison of Fc-receptor structures. , 2001, Journal of molecular biology.
[31] Jeffrey C. Boyington,et al. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand , 2000, Nature.
[32] A. Neil Barclay,et al. 2B4, the Natural Killer and T Cell Immunoglobulin Superfamily Surface Protein, Is a Ligand for CD48 , 1998, The Journal of experimental medicine.
[33] A. Sanchez,et al. Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins. , 1998, Science.
[34] B K Jakobsen,et al. T cell receptor and coreceptor CD8 alphaalpha bind peptide-MHC independently and with distinct kinetics. , 1999, Immunity.
[35] P. Sun,et al. Crystal structure of the HLA-Cw3 allotype-specific killer cell inhibitory receptor KIR2DL2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[36] H. Ploegh,et al. Viral subversion of the immune system. , 2000, Annual review of immunology.
[37] S. Ikemizu,et al. CD2 and the nature of protein interactions mediating cell‐cell recognition , 1998, Immunological reviews.
[38] J. Levy,et al. The FC and not CD4 receptor mediates antibody enhancement of HIV infection in human cells. , 1989, Disease markers.
[39] Z Reich,et al. Ligand recognition by alpha beta T cell receptors. , 1998, Annual review of immunology.
[40] J. V. D. van de Winkel,et al. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. , 1993, Immunology today.
[41] B K Jakobsen,et al. TCR binding to peptide-MHC stabilizes a flexible recognition interface. , 1999, Immunity.
[42] R. Ghirlando,et al. Stoichiometry and thermodynamics of the interaction between the Fc fragment of human IgG1 and its low-affinity receptor Fc gamma RIII. , 1995, Biochemistry.
[43] Y. Tominaga,et al. Affinity and kinetic analysis of the molecular interaction of ICAM-1 and leukocyte function-associated antigen-1. , 1998, Journal of immunology.
[44] Eric O Long,et al. Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptors , 1997, Nature.
[45] Stephen P. Young,et al. Role of Oligosaccharide Residues of IgG1-Fc in FcγRIIb Binding* , 2001, The Journal of Biological Chemistry.
[46] C. Sautès-Fridman,et al. Structural basis of the interaction between IgG and fcγ receptors , 2000 .
[47] P. Barton,et al. Biochemical analysis and crystallisation of FcγRIIa, the low affinity receptor for IgG , 1999 .